Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07732504) titled 'AI-Guided Surveillance and Curative Salvage of Recurrence After Hepatocellular Carcinoma Resection or Ablation' on July 23.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: Single (Outcomes Assessor).

Primary Sponsor: Tongji Hospital

Condition: Hepatocellular Carcinoma (HCC)

Intervention: Other: Artificial Intelligence-Guided Risk-Adapted Surveillance

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 1, 2026

Target Sample Size: 2000

Countries of Recruitment: China

T...